<div id="readability-page-1"><div><p>As global markets navigate the complexities of geopolitical tensions and shifting monetary policies, U.S. stocks have shown resilience with major indexes posting gains despite a hawkish Federal Reserve stance and fluctuating oil prices. In this context, identifying high-growth tech stocks involves looking for companies that demonstrate robust earnings potential and innovation in sectors like artificial intelligence, which are poised to benefit from current market dynamics.</p><h3>Top 10 High Growth Tech Companies Globally</h3><div><table><tbody><tr><th>Name</th><th>Revenue Growth</th><th>Earnings Growth</th><th>Growth Rating</th></tr><tr><td>Hacksaw</td><td>25.39%</td><td>24.90%</td><td>★★★★★★</td></tr><tr><td>Shengyi Electronics</td><td>26.78%</td><td>32.30%</td><td>★★★★★★</td></tr><tr><td>Delton Technology (Guangzhou)</td><td>29.71%</td><td>33.06%</td><td>★★★★★★</td></tr><tr><td>Zhongji Innolight</td><td>41.90%</td><td>44.62%</td><td>★★★★★★</td></tr><tr><td>Suzhou TFC Optical Communication</td><td>44.06%</td><td>41.48%</td><td>★★★★★★</td></tr><tr><td>Fositek</td><td>29.55%</td><td>39.17%</td><td>★★★★★★</td></tr><tr><td>Unimicron Technology</td><td>29.87%</td><td>54.56%</td><td>★★★★★★</td></tr><tr><td>KebNi</td><td>26.87%</td><td>82.69%</td><td>★★★★★★</td></tr><tr><td>Co-Tech Development</td><td>34.37%</td><td>65.79%</td><td>★★★★★★</td></tr><tr><td>CARsgen Therapeutics Holdings</td><td>64.21%</td><td>83.56%</td><td>★★★★★★</td></tr></tbody></table></div><p>Click here to see the full list of 197 stocks from our Global High Growth Tech and AI Stocks screener.</p><p>Here we highlight a subset of our preferred stocks from the screener.</p><h2>Pharming Group (ENXTAM:PHARM)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★★☆</p><p><strong>Overview:</strong> Pharming Group N.V. is a biopharmaceutical company that focuses on developing and commercializing protein replacement therapies and precision medicines for rare diseases across the United States, Europe, and internationally, with a market cap of €1.01 billion.</p><p><strong>Operations:</strong> Pharming Group generates revenue primarily from its products Joenja® and Ruconest®, contributing $58.21 million and $317.92 million, respectively. The company is involved in the biopharmaceutical sector, focusing on rare diseases with a market cap of approximately €1 billion.</p><p>Pharming Group's recent advancements and financial growth reflect its potential in the biotech sector, particularly with its pioneering treatment, Joenja, for APDS. The company reported a significant turnaround with annual revenue rising to $376.13 million, up from $297.2 million the previous year, and transitioning from a net loss of $11.84 million to a net profit of $2.85 million. This resurgence is bolstered by strategic conference presentations and positive clinical trial outcomes that enhance its market presence in Europe and Japan. With an expected earnings growth of 36.7% per year and R&amp;D focused on addressing rare diseases through innovative treatments, Pharming is positioning itself as a key player in specialized healthcare solutions.</p><ul><li>Unlock comprehensive insights into our analysis of Pharming Group stock in this health report.</li><li>Understand Pharming Group's track record by examining our Past report.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0b975b67-eb09-4f0d-a0c0-7a08bd4f1141/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/0b975b67-eb09-4f0d-a0c0-7a08bd4f1141/chart/revenue-and-expenses-breakdown"/><figcaption>ENXTAM:PHARM Revenue and Expenses Breakdown as at May 2026</figcaption></figure><h2>CELSYS (TSE:3663)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> CELSYS, Inc. operates in Japan providing content creation solutions and has a market cap of approximately ¥39.85 billion.</p><p><strong>Operations:</strong> The company focuses on providing content creation solutions in Japan. It generates revenue primarily through software sales and related services, with a notable emphasis on digital illustration and animation tools.</p><p>CELYS has demonstrated resilience and strategic foresight in its financial operations, particularly evident in its recent corporate actions to optimize treasury shares. With a projected annual earnings growth of 22.3% and revenue increases at 9.7% per year, the company is outpacing the Japanese market average significantly. These figures are bolstered by robust R&amp;D investments that not only underscore CELSYS's commitment to innovation but also align with broader industry trends towards enhanced digital solutions. Recent dividend adjustments reflect a tactical approach to shareholder returns, balancing between reinvestment in growth and direct shareholder value enhancement through dividends expected to rise from JPY 14.00 to JPY 20.00 per share annually.</p><ul><li>Delve into the full analysis health report here for a deeper understanding of CELSYS.</li><li>Review our historical performance report to gain insights into CELSYS''s past performance.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/850a7a11-e4be-477b-8270-7d157f2aada2/chart/earnings-and-revenue-growth?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/850a7a11-e4be-477b-8270-7d157f2aada2/chart/earnings-and-revenue-growth"/><figcaption>TSE:3663 Earnings and Revenue Growth as at May 2026</figcaption></figure><h2>Plus Alpha ConsultingLtd (TSE:4071)</h2><p><strong>Simply Wall St Growth Rating:</strong> ★★★★☆☆</p><p><strong>Overview:</strong> Plus Alpha Consulting Co., Ltd. offers marketing and HR solutions within Japan, with a market capitalization of ¥92.33 billion.</p><p><strong>Operations:</strong> Plus Alpha Consulting Co., Ltd. generates revenue primarily through its HR solutions, which account for ¥13.84 billion, and marketing solutions, contributing ¥3.79 billion. The company operates exclusively within Japan's market, focusing on these two key segments to drive its business operations.</p><p>Plus Alpha ConsultingLtd. has recently shown robust financial performance, with a notable increase in quarterly sales from JPY 3.89 billion to JPY 4.44 billion and a surge in net income from JPY 755.55 million to JPY 1.15 billion year-over-year. This growth trajectory is supported by an annual revenue growth rate of 12.5%, outpacing the Japanese market's average of 6%. The company's commitment to innovation is evident from its R&amp;D spending trends, aligning with industry shifts towards more sophisticated digital solutions and ensuring competitiveness in the evolving tech landscape.</p><ul><li>Click to explore a detailed breakdown of our findings in Plus Alpha ConsultingLtd's health report.</li><li>Learn about Plus Alpha ConsultingLtd's  historical performance.</li></ul><figure><img height="476" src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a6c28592-bcb7-4305-8f5b-f6b1e621ab4b/chart/revenue-and-expenses-breakdown?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" width="746" original-src="https://imageproxy.pbkrs.com/https://images.simplywall.st/company/a6c28592-bcb7-4305-8f5b-f6b1e621ab4b/chart/revenue-and-expenses-breakdown"/><figcaption>TSE:4071 Revenue and Expenses Breakdown as at May 2026</figcaption></figure><h2>Seize The Opportunity</h2><ul><li>Click this link to deep-dive into the 197 companies within our Global High Growth Tech and AI Stocks screener.</li><li>Already own these companies? Link your portfolio to Simply Wall St and get alerts on any new warning signs to your stocks.</li><li>Invest smarter with the free Simply Wall St app providing detailed insights into every stock market around the globe.</li></ul><h2>Ready For A Different Approach?</h2><ul><li>Explore high-performing small cap companies that haven't yet garnered significant analyst attention.</li><li>Fuel your portfolio with companies showing strong growth potential, backed by optimistic outlooks both from analysts and management.</li><li>Find companies with promising cash flow potential yet trading below their fair value.</li></ul> <p><em> This article by Simply Wall St is general in nature. <strong>We provide commentary based on historical data      and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice.</strong> It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your      financial situation. We aim to bring you long-term focused analysis driven by fundamental data.      Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material.      Simply Wall St has no position in any stocks mentioned.</em></p><div><h3><strong>New: </strong>Manage All Your Stock Portfolios in One Place</h3><p>We've created the <strong>ultimate portfolio companion</strong> for stock investors, <strong>and it's free.</strong></p><p>• Connect an unlimited number of Portfolios and see your total in one currency<br/>• Be alerted to new Warning Signs or Risks via email or mobile<br/>• Track the Fair Value of your stocks<br/></p><p>Try a Demo Portfolio for Free</p></div></div></div>

ARKG

SBIO

<p>As global markets face geopolitical tensions and changing monetary policies, U.S. stocks remain resilient. High-growth tech stocks are highlighted, particularly in sectors like AI. Notable companies include Pharming Group, CELSYS, and Plus Alpha Consulting, each showing strong revenue and earnings growth. Pharming Group reported a revenue increase to $376.13 million and a net profit of $2.85 million, while CELSYS and Plus Alpha Consulting also demonstrated significant growth in their respective markets. These companies are positioned well for future growth amid current market dynamics.</p>

High Growth Tech Stocks To Watch In May 2026